News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celltech Group PLC (CLL) And Biogen Idec, Inc. (Massachusetts) (BGEN) Announce Autoimmune Disease Collaboration



10/19/2005 5:09:56 PM

Celltech Group plc (LSE:CCH) (NYSE:CLL) and Biogen Idec (Nasdaq:BIIB) announce that they have entered into a collaboration for the research, development and commercialisation of antibodies against the CD40 ligand (CD40L) protein for the treatment of autoimmune diseases.

Read at Reuters
Read at Prime Zone


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES